ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in RPRX — Royalty Pharma plc

CIK 1165408 Boston, MA

Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$140,175,000

-$218,670,965 QoQ

Shares Held

2,500,000

-66.6% QoQ

Ownership

0.435%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#28

of 646 holders

Holding Since

Jun 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. RPRX ranks #8 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	10,349,328	$366,262,717
2	PRAX	Praxis Precision Medicines, Inc.	1,015,480	$339,972,549
3	VRTX	Vertex Pharmaceuticals Inc / Ma	393,964	$195,693,737
4	TNGX	Tango Therapeutics, Inc.	5,600,000	$175,056,000
5	BBIO	BridgeBio Pharma, Inc.	2,252,000	$167,728,960
6	SYRE	Spyre Therapeutics, Inc.	1,722,300	$152,905,794
7	TVTX	Travere Therapeutics, Inc.	2,569,356	$145,965,114
8	RPRX	Royalty Pharma plc This page	2,500,000	$140,175,000

All Filings in RPRX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$140,175,000	2,500,000	-66.6%	Shares	Sole	2026-08-14
2026-03-31	$358,845,965	7,480,633	-36.3%	Shares	Sole	2026-05-15
2025-12-31	$453,656,552	11,740,594	-1.9%	Shares	Sole	2026-02-17
2025-09-30	$422,147,532	11,965,633	+99.4%	Shares	Sole	2025-11-14
2025-06-30	$216,180,000	6,000,000	-4.0%	Shares	Sole	2025-08-14
2025-03-31	$194,562,500	6,250,000	-63.2%	Shares	Sole	2025-05-15
2024-12-31	$432,861,868	16,968,321	+42.6%	Shares	Sole	2025-02-14
2024-09-30	$336,628,198	11,899,194	+8.8%	Shares	Sole	2024-11-14
2024-06-30	$288,275,020	10,931,931	+1.1%	Shares	Sole	2024-08-14
2024-03-31	$328,510,194	10,816,931	-0.7%	Shares	Sole	2024-05-15
2023-12-31	$306,094,791	10,896,931	+10.7%	Shares	Sole	2024-02-14
2023-09-30	$267,057,600	9,840,000	+13.8%	Shares	Sole	2023-11-14
2023-06-30	$265,901,000	8,650,000	+19.4%	Shares	Other	2023-08-14
2023-03-31	$261,032,558	7,244,867	+3.5%	Shares	Sole	2023-05-15
2022-12-31	$276,640,000	7,000,000	-14.3%	Shares	Sole	2023-02-14
2022-09-30	$328,069,700	8,165,000	-51.1%	Shares	Sole	2022-11-14
2022-06-30	$702,396,542	16,707,815	-32.7%	Shares	Sole	2022-08-15
2022-03-31	$967,872,176	24,842,715	0.0%	Shares	Sole	2022-05-16
2021-12-31	$989,982,192	24,842,715	+0.6%	Shares	Sole	2022-02-14
2021-09-30	$892,579,034	24,697,815	+8.7%	Shares	Sole	2021-11-15
2021-06-30	$931,367,196	22,721,815	-8.0%	Shares	Sole	2021-08-16
2021-03-31	$1,076,879,916	24,687,756	-36.2%	Shares	Sole	2021-05-17
2020-12-31	$1,937,649,714	38,714,280	-15.9%	Shares	Sole	2021-02-16
2020-09-30	$1,935,864,933	46,015,330	0.0%	Shares	Sole	2020-11-16
2020-06-30	$2,234,044,271	46,015,330	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.